Sign Up to like & get
recommendations!
1
Published in 2022 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.01056-22
Abstract: The F1FO-ATP synthase is required for the viability of tuberculosis (TB) and nontuberculous mycobacteria (NTM) and has been validated as a drug target. Here, we present the cryo-EM structures of the Mycobacterium smegmatis F1-ATPase and…
read more here.
Keywords:
synthase;
tuberculosis nontuberculous;
atp synthase;
atp synthesis ... See more keywords